Atherosclerosis
Volume 212, Issue 1 , Pages 63-69 , September 2010

Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice

  • Shoukang Zhu

      Affiliations

    • Miller School of Medicine, University of Miami, FL 33101, United States
    • These authors made equal contributions to this work.
    • ,
  • Anuj Malhotra

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
    • These authors made equal contributions to this work.
    • ,
  • Lisheng Zhang

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
    • ,
  • Shanming Deng

      Affiliations

    • Miller School of Medicine, University of Miami, FL 33101, United States
    • ,
  • Taifang Zhang

      Affiliations

    • Miller School of Medicine, University of Miami, FL 33101, United States
    • ,
  • Neil J. Freedman

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
    • ,
  • Robert Storms

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
    • ,
  • Karsten Peppel

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
    • ,
  • Pascal J. Goldschmidt-Clermont

      Affiliations

    • Miller School of Medicine, University of Miami, FL 33101, United States
    • ,
  • Chunming Dong

      Affiliations

    • Miller School of Medicine, University of Miami, FL 33101, United States
    • Corresponding Author InformationCorresponding author at: Department of Medicine, 1501 NW 10th Avenue, BRB-812, University of Miami, Miami, FL 33136, United States. Tel.: +1 305 243 4706; fax: +1 305 243 5584.

Received 24 November 2009 ,Revised 13 April 2010 ,Accepted 14 April 2010.

References 

  1. Zwolak RM, Adams MC, Clowes AW. Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg. 1987;5(1):126–136
  2. Eslami MH, Gangadharan SP, Belkin M, et al. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?. J Vasc Surg. 2001;34(5):923–929
  3. Mann MJ, Dzau VJ. Genetic manipulation of vein grafts. Curr Opin Cardiol. 1997;12(6):522–527
  4. Zhang L, Peppel K, Brian L, Chien L, Freedman NJ. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol. 2004;24(12):2277–2283
  5. Dong C, Crawford LE, Goldschmidt-Clermont PJ. Endothelial progenitor obsolescence and atherosclerotic inflammation. J Am Coll Cardiol. 2005;45(9):1458–1460
  6. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964–967
  7. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105(1):71–77
  8. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1–E7
  9. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593–600
  10. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105(11):1527–1536
  11. Vaziri H, Dragowska W, Allsopp RC, et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA. 1994;91(21):9857–9860
  12. Goodwin HS, Bicknese AR, Chien SN, et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant. 2001;7(11):581–588
  13. Zhu S, Liu X, Li Y, Goldschmidt-Clermont PJ, Dong C. Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2007;27(1):113–119
  14. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 2003;108(4):457–463
  15. Zhang L, Hagen PO, Kisslo J, Peppel K, Freedman NJ. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model. J Vasc Surg. 2002;36(4):824–832
  16. Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res. 2003;93(8):e76–e86
  17. Mayr U, Zou Y, Zhang Z, et al. Accelerated arteriosclerosis of vein grafts in inducible NO synthase(−/−) mice is related to decreased endothelial progenitor cell repair. Circ Res. 2006;98(3):412–420
  18. Sainz J, Sata M. Maintenance of vascular homeostasis by bone marrow-derived cells. Arterioscler Thromb Vasc Biol. 2006;26(6):1196–1197
  19. Murugesan S, Mousa SA, O’connor LJ, Lincoln DW, Linhardt RJ. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett. 2007;581(6):1157–1160
  20. Zhang L, Freedman NJ, Brian L, Peppel K. Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler Thromb Vasc Biol. 2004;24(3):470–476
  21. He T, Smith LA, Harrington S, et al. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke. 2004;35(10):2378–2384
  22. Kong D, Melo LG, Gnecchi M, et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation. 2004;110(14):2039–2046
  23. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41–49
  24. Hinokiyama K, Valen G, Tokuno S, Vedin JB, Vaage J. Vein graft harvesting induces inflammation and impairs vessel reactivity. Ann Thorac Surg. 2006;82(4):1458–1464
  25. Leonard EJ, Skeel A, Yoshimura T. Biological aspects of monocyte chemoattractant protein-1 (MCP-1). Adv Exp Med Biol. 1991;305:57–64
  26. Tatewaki H, Egashira K, Kimura S, et al. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J Vasc Surg. 2007;45(6):1236–1243
  27. Selzman CH, Miller SA, Zimmerman MA, et al. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol. 2002;283(4):H1455–H1461
  28. Schepers A, Eefting D, Bonta PI, et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2006;(9):2063–2069

PII: S0021-9150(10)00308-4

doi: 10.1016/j.atherosclerosis.2010.04.018

Atherosclerosis
Volume 212, Issue 1 , Pages 63-69 , September 2010

Article Tools

* Image Usage & Resolution